Overcoming challenges in cancer research, diagnosis and therapy.

Cancer Diagnosis and Therapy Congress

About the Congress

Cancer with all the recent developments in diagnosis and treatments, is still one of the leading causes of global deaths. Organizations world over are taking efforts to make new head-ways in curing cancer; some of them even collaborating their efforts and resources.

Aiding these efforts and with an aim to bring global experts under one roof Markets and Markets Conferences is organizing Cancer Diagnosis and Therapy Congress in London - UK on 3 - 4 September 2015. Attend the congress to meet industry peers and stay updated with the latest developments in oncology. Download agenda for more details.

Presenters at the Congress

  • Celgene, USA
  • Agenus & 4-Antibody AG, Switzerland
  • Imperial College London, UK
  • Queen’s University Belfast, UK
  • University of Manchester, UK
  • APeX Disease Reserch Institute, USA
  • Queen Mary University of London, UK
  • Nanomerics Ltd, UK and many more.

Why attend this Congress?

  • This event is one of a kind addressing issues in both diagnosis and therapy.
  • Key technologies to be discussed at the congress include
    - Immunotherapy
    - New diagnosis techniques such as TACP, LITT and RFA among others.
    - Biomarker approach
  • This event is unique covering regulatory aspects such as Biobanking, Repurposing FDA approve drugs and NCRN trials portfolio.
  • Featured at the event will be 20+ case studies on application of new technologies in cancer diagnosis and therapy.
  • Get a chance to interact with 40+ medical experts from global hospitals and research institutes.
  • The programme is detailed to look at thepractical applications of research and technology.

Register for the Congress

The congress through an effective blend of presentations and case studies will address key topics such as

  • Emerging challenges in organ specific cancer research
  • Nano-enabled delivery of cancer therapies
  • New methods in cancer reversals
  • Electrochemical biosensors for prostate cancer diagnosis
  • Biobanking international harmonization & globalization
  • Developing adoptive cell therapy for cancer

We are providing a Early Registration discount of 15% on registration fees till 31st May 2015. Take advantage of the offer, email for more information.

Warm Regards,

Oliver Smith
Marketing Manager | MnM Conferences